Scholar Profile
Angela She
Biotechnology
Biography
Angela graduated Phi Beta Kappa from Yale University in 2012 with a B.S. in Chemistry. She completed her Ph.D. in Chemical Biology at Harvard University in 2017, with a focus on small molecule probe and drug discovery towards rare neurodegenerative diseases. She was a National Science Foundation Graduate Research Fellow and a Board Member of Harvard's Science in the News, an organization that seeks to make science accessible to the public. She worked across venture creation and biotech startup spaces after her PhD and is currently Vice President of R&D Operations at Viridian Therapeutics, a biotech company in Waltham, Massachusetts focused on antibody therapeutics to treat rare disease.
High school: North Hollywood High School
Degrees
| College | Year | Degree |
|---|---|---|
Yale CollegeNew Haven, CT |
2012 | B.S. Intensive Chemistry |
Harvard UniversityCambridge, MA |
2017 | Ph.D. Chemical Biology |
News and Highlights
Big Step in Biotech: Congratulations to Angela She, MS ’08, for starting a new position as Chief of Staff at Viridian Therapeutics, Inc. Angela will be working in on life-changing projects for this cutting edge biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies.
Supporting Science: Congratulations are in order for Angela She, MS ‘08, who was recently awarded the National Science Foundation’s prestigious Graduate Research Fellowship (GRFP) to continue her work at Harvard University in their Chemical Biology Ph.D. program.